Abstract: Disclosed are methods and systems of providing carbon nanotubes decorated with polymer coated metal nanoparticles. Then, annealing the metal coated carbon nanotubes to reduce a quantity of hydrophilic components of the polymer coating.

Abstract: Embodiments of the present disclosure provide techniques for performing searches of event records by leveraging reference values in an inverted index. A method of searching comprises accessing a query associated with a first set of event records in a field searchable data store, each event record comprising a time-stamped portion of raw machine data. The method further comprises evaluating the query and generating results for the query by accessing an inverted index, wherein each entry in the inverted index comprises at least one field, a corresponding at least one field value and a reference value that identifies a location in the field searchable data store where an associated event record is stored. The method further comprises performing a search to filter out a second set of event records and retrieving the second set of event records from the field searchable data store using reference values in the inverted index.

Abstract: A processor-implemented method includes generating, by a scheduling model, a group of schedules from a computation graph associated with a task, each node on the computation graph being associated with an operation of an artificial neural network, each schedule of the group of schedules associating each node of the computation graph with a processor of a group of processors of a hardware device. The processor-implemented method also includes testing one or more schedules of the group of schedules on the hardware device or a model of the hardware device. The processor-implemented method further includes selecting a schedule of the one or more schedules based on testing the one or more schedules, the selected schedule satisfying a selection condition.

Abstract: The invention provides for delivery, engineering and optimization of systems, methods, and compositions for manipulation of sequences and/or activities of target sequences. Provided are delivery systems and tissues or organ which are targeted as sites for delivery. Also provided are vectors and vector systems some of which encode one or more components of a CRISPR complex, as well as methods for the design and use of such vectors. Also provided are methods of directing CRISPR complex formation in eukaryotic cells to ensure enhanced specificity for target recognition and avoidance of toxicity and to edit or modify a target site in a genomic locus of interest to alter or improve the status of a disease or a condition.

Abstract: In various examples, sensor data may be collected using one or more sensors of an ego-vehicle to generate a representation of an environment surrounding the ego-vehicle. The representation may include lanes of the roadway and object locations within the lanes. The representation of the environment may be provided as input to a longitudinal speed profile identifier, which may project a plurality of longitudinal speed profile candidates onto a target lane. Each of the plurality of longitudinal speed profiles candidates may be evaluated one or more times based on one or more sets of criteria. Using scores from the evaluation, a target gap and a particular longitudinal speed profile from the longitudinal speed profile candidates may be selected. Once the longitudinal speed profile for a target gap has been determined, the system may execute a lane change maneuver according to the longitudinal speed profile.

Abstract: The present disclosure provides compounds which are immunomodulators and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.

Abstract: Systems and methods for a unified approach that is compatible with all blockchains, protocols, etc. The systems and methods use a bifurcated indexing system with a dynamically selected application service. The systems and methods bifurcate the indexing process into a storage layer and a compute layer.

Abstract: Compounds and methods for preventing and/or treating one or more symptoms of sickle cell diseases (SCD) by administering at least one of the compounds are provided. The compounds are chemically modified to increase bioavailability and activity, e.g., so that the compounds prevent adhesion and sickling of red blood cells (RBCs).

Abstract: The invention provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides non-naturally occurring or engineered RNA-targeting systems comprising a novel RNA-targeting CRISPR effector protein and at least one targeting nucleic acid component like a guide RNA.

Abstract: The present invention provides a locking mechanism in a mobile terminal and a method of manufacturing the same. The locking mechanism comprises a slider, latch, button, and spring. The slider and latch include openings and may translate between a locked position and an unlocked position. The latch may include a protrusion that limits the translation of the slider and the latch when in the locked position. The button is located within the opening of the slider and the opening of the latch, and the spring member is fixed adjacent the latch. In an instance in which an external force is applied to the button, the external force deforms the spring member such that contact between a vertical edge of the protrusion and the spring is precluded allowing translation of the slider and the latch between the locked position and the unlocked position.

Abstract: The disclosure relates to a table (100). The table (100) has a table top (102), a plurality of legs (104) connectable to the table top (102), and an air purifier (106) adapted to be placed below the table top (102). A bottom side of the table top (102) is provided with at least one groove (112) extending in a circumferential direction for preventing liquid from traveling from an outer edge of the table top (102) along the bottom side of the table top (102) and reaching an inner section of the air purifier (106). The disclosure also relates to a method for purifying air using a table (100).

Abstract: The present disclosure is directed to processing imagery using one or more machine learning (ML) models. In particular, data describing imagery comprising a plurality of different and distinct frames can be received; and based at least in part on one or more ML models and the data describing the imagery, and for each frame of the plurality of different and distinct frames, one or more scores can be determined for the frame. Each score of the score(s) can indicate a determined measure of suitability of the frame with respect to one or more of various different and distinct uses for which the ML model(s) are configured to determine suitability of imagery.

Abstract: Examples of a suspension are provided. The suspension includes a mount plate attached to a load beam at a suspension assembly attachment point. The suspension may include a first actuator and a second actuator located at the mount plate. The first actuator is shaped as a non-right angle parallelogram spanning across a first opening in the mount plate. The second actuator is shaped as a non-right angle parallelogram spanning across a second opening in the mount plate. The first and second actuators are configured to deflect the distal end of the mount plate, which causes the load beam to rotate with a rotation center located along the load beam.

Abstract: Methods, nodes and computer program products control radio channel deployment when using un-licensed carriers in a wireless communication network and control mobility and/or load balancing target selection when using un-licensed carriers. When performed in an access node, unlicensed carrier intrinsic cell channel load is determined in a cell served by the access node based on one or more predetermined channel load indicators and neighbor cell channel load information is obtained, from one or more neighboring access nodes. The neighbor cell channel load information includes unlicensed carrier channel load in respective cells based on the one or more predetermined channel load indicators. At least one channel deployment operation is initiated based on an outcome of one or more comparative operations including the determined unlicensed carrier intrinsic cell channel load and/or the obtained neighbor cell channel load information.

Abstract: The present disclosure provides compounds of Formula (I) and Formula (II), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs thereof. The provided compounds may be kinase (e.g., Janus kinase (JAK) (e.g., Janus kinase 2 (JAK2)) and/or cyclin-dependent kinase (CDK) (e.g., cyclin-dependent kinase 11 (CDK11)) inhibitors. Also provided are pharmaceutical compositions and kits including the provided compounds. Further provided are methods of using the provided compounds, pharmaceutical compositions, and kits (e.g., for treating a disease (e.g., proliferative disease) in a subject in need thereof).

Abstract: A computing device includes: a housing having a plurality of sides defining a housing interior; a first outer lens disposed on a first side of the housing; a second outer lens disposed on a second side of the housing; an image sensor in the housing interior, the image sensor having first and second capture regions; an optical divider in the housing interior, the optical divider configured to (i) direct light from the first outer lens along a first optical path, and (ii) direct light from the second outer lens along a second optical path; and a lens assembly between the optical divider and the image sensor, the lens assembly configured to (i) focus light received along the first optical path onto the first capture region of the image sensor, and (ii) focus light received along the second optical path onto the second capture region of the image sensor.

Abstract: The present disclosure relates to peptidic compounds of Formula A, A-II, A-III, B, or C, or salt or solvate thereof, compositions thereof, and methods of use thereof. The compounds of the present disclosure are useful for targeting CXCR4 for purposes such as imaging and/or therapeutics.

Abstract: The present invention is directed to QTY CCR9 and CXCR2 variant Fc receptor fusion proteins, methods for the preparation thereof and methods of use thereof.

Abstract: This disclosure describes, in part, systems for enabling facilities to implement techniques to determine when users are in possession of items when located within and/or exiting the facilities. For instance, a system may use one or more sensors to determine locations of a user that navigated through a facility. Additionally, the system may use one or more sensors to determine locations of an item while the item was located within the facility. The system may then determine a probability that the user was in possession of the item when in the facility and/or when exiting the facility based at least in part on the locations of the user and the locations of the item. If the system determines that the user was in possession of the item when exiting the facility, the system may charge a payment instrument of the user for a price of the item.

Abstract: A device may receive network data identifying a topology of network devices of a network, quality of service (QoS) rules for user equipment (UEs) and application flows associated with the network, QoS profiles for a radio access network (RAN) of the network, and service data flow (SDF) templates. The device may process the network data, with a model, to calculate a network device service level agreement (SLA) score, for each of the network devices on a sliding window, to generate network device SLA scores, and may aggregate the network device SLA scores to generate an end-to-end SLA score on the sliding window. The device may generate QoS configuration data based on the end-to-end SLA score, and may implement the QoS configuration data.